BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25581523)

  • 1. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
    Mehta A; Chowdhary M; Sinha R
    J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
    Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
    Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
    Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
    World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
    Sarkis SA; Abdullah BH; Abdul Majeed BA; Talabani NG
    Head Neck Oncol; 2010 Jun; 2():13. PubMed ID: 20579333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.
    Bhuvaneswari R; Ng QF; Thong PS; Soo KC
    Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
    Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
    Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
    da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
    Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study.
    Pontes HA; Pontes FS; de Jesus AS; Soares MC; Gonçalves FL; de Lucena Botelho T; do Carmo Ribeiro J; Dos Santos Pinto D
    J Oral Pathol Med; 2015 Aug; 44(7):532-7. PubMed ID: 25244056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
    Aquino G; Pannone G; Santoro A; Liguori G; Franco R; Serpico R; Florio G; De Rosa A; Mattoni M; Cozza V; Botti G; Losito S; Longo F; Staibano S; Cuda G; Lo Muzio L; Sbordone C; Bufo P; Grimaldi A; Caraglia M; Di Domenico M
    Cancer Biol Ther; 2012 Sep; 13(11):967-77. PubMed ID: 22825335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
    Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
    J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
    BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.